Hostname: page-component-8448b6f56d-cfpbc Total loading time: 0 Render date: 2024-04-19T22:53:20.995Z Has data issue: false hasContentIssue false

Schizophrenia: improving the treatment through increased understanding

Published online by Cambridge University Press:  16 April 2020

Robin M. Murray*
Affiliation:
Institute of Psychiatry Division of Psychological Medicine, De Crespigny Park, Denmark Hill, LondonSE5 8AF (UK)

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © 2003 European Psychiatric Association

References

Geddes, J, Freemantle, N, Harrisson, P, Bebbington, P.Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 2000; 321:1371–6CrossRefGoogle ScholarPubMed
Gray, JA, Feldon, J Rawlins JNP, Heursley, RR, Smith, AD. The neuropsychology of schizophrenia. Behav Brain Sci 1991,14, 1-84.CrossRefGoogle Scholar
Murray, RM, Jones, PB, Sussere, E, van Os, J, Cannon, M.The epidemiology of schizophrenia. Cambridge: Cambridge University Press; 2003.Google Scholar
Tsapakis, EM, Guillin, O, Murrary, RM. Does dopamine sensitisation underlie the association between schizophrenia and drug abuse? Curr Opin Psychiatry 2003;16:S45-S52.CrossRefGoogle Scholar
UK 700 Group: Burns, T, Creed, F, Faby, T, Thomson, S, Tyrer, P, White, I.Intensive versus standard case management for severe psychotic illness: a randomised trial. Lancet 1999;353:2185–9.CrossRefGoogle ScholarPubMed
Wright, IC, Rabe-Hesketh, S, Wooddruff, PWR, David, AS, Murray, M, Bullmore, ET. Metat-analysis of regional brain volumes in schizophrenia. Am J Psychiatr 2000;157:16–25.CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.